Gene · 4921
NIH grants1,545
NIH grants whose papers are about the gene, through NIH's grant-paper links.
381 to 400 of 1,545
Download this page as JSON| Grant | Title | DDR2 papers | Newest fiscal year |
|---|---|---|---|
| R37CA219697 | IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA | 1 | 2024 |
| R37CA228304 | Crosstalk Between the ER Stress Response and Mitochondrial Fatty Acid Oxidation in MYC-driven Breast Cancer | 1 | 2024 |
| SC1GM121182 | Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer | 1 | 2024 |
| T32CA009666 | Research Training in Academic Medical Oncology | 1 | 2024 |
| T32CA062948 | Cancer Pharmacology | 1 | 2024 |
| T32ES007020 | Training Grant in Environmental Toxicology | 1 | 2024 |
| T32HL007910 | Basic Sciences Studies on Gene Therapy of Blood Diseases | 1 | 2024 |
| T32HL098040 | TRAINING PROGRAM IN LUNG BIOLOGY AND DISEASE | 1 | 2024 |
| U01CA200147 | The second phase of NIH Common Fund 4D Nucleome Network Organizational Hub | 1 | 2024 |
| U19AI067773 | Center for High-Throughput Minimally-Invasive Radiation Biodosimetry | 1 | 2024 |
| U24MH068457 | Limited Competition: Continuation of the Center for Genomic Studies on Mental Disorders | 1 | 2024 |
| U54CA254566 | Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging | 1 | 2024 |
| UL1TR001442 | UC San Diego Clinical and Translational Research Institute | 1 | 2024 |
| ZIAAG000361 | NRF2 interactions with SIRT1 and its role on caloric restriction | 1 | 2024 |
| ZIABC008753 | Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies | 1 | 2024 |
| ZIASC009179 | The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis | 1 | 2024 |
| R01CA234553 | Role of the microenvironment in ovarian cancer metastasis | 4 | 2023 |
| P01CA240239 | Strategies to Overcome Immune Resistance in Head and Neck Cancers | 3 | 2023 |
| R01CA125577 | Role of CCN6 (WISP3) in the progression and metastasis of breast cancer | 3 | 2023 |
| P50CA100632 | SPORE University of Texas M. D. Anderson Cancer Center-Leukemia | 2 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/grants?page=20